Back to search
FDAFDA · Food and drugs·Recall number D-66447-001

Irinotecan Hydrochloride Injection, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial per carton, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Schiffgraben 23, 38690 Vienenburg, Germany; Distributed by: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA, NDC 0143-9702-01.

Published November 13, 2013 · Recall initiated: September 23, 2013

Summary

FDA records drug Class II recall D-66447-001, published November 13, 2013 and initiated September 23, 2013. Recalling firm: West-Ward Pharmaceutical Corp.; Status: Terminated; Reported quantity: 9020 vials; Lot: Lot #: AC0020, Exp 03/14; AC0023, AC0025, Exp 08/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug: a recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation which will result in an assay higher than the labeled claim.

What to do

Voluntary: Firm initiated · Letter

Get an email if IRINOTECAN HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
IRINOTECAN HYDROCHLORIDE
Manufacturer
West-Ward Pharmaceutical Corp.
Distributor
Nationwide
UPC
0301439701019
Lot
Lot #: AC0020, Exp 03/14; AC0023, AC0025, Exp 08/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Irinotecan Hydrochloride Injection, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial per carton, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Schiffgraben 23, 38690 Vienenburg, Germany; Distributed by: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA, NDC 0143-9702-01. recalled?

Yes. FDA published recall D-66447-001 on November 13, 2013. Reported hazard: Superpotent Drug: a recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation which will result in an assay higher than the labeled claim.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: IRINOTECAN HYDROCHLORIDE. UPC: 0301439701019.